Characterization of Phenotype and Genotype of Early Onset Enteropathies
NCT02614911 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1445
Last updated 2025-04-30
Summary
This study has been set up in order to characterize phenotypes and genotypes of patients with early onset enteropathies.
In that goal, Investigators will collect biological samples (mainly blood) of patients suffering from early onset enteropathies and their healthy relatives.
Conditions
Interventions
- OTHER
-
Biological sampling
Biological sampling including blood, feces, biopsies...
Sponsors & Collaborators
-
Imagine Institute
lead OTHER
Principal Investigators
-
Frank Ruemmele · Necker - Enfants Malades Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-16
- Primary Completion
- 2054-06-15
- Completion
- 2054-06-15
Countries
- France
Study Locations
More Related Trials
-
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
NCT02502552 ·Status: COMPLETED
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease
NCT02693340 ·Status: UNKNOWN
-
Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients
NCT05927064 ·Status: COMPLETED
-
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387 ·Status: RECRUITING
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease
NCT02909244 ·Status: COMPLETED
-
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
NCT02826330 ·Status: COMPLETED
-
Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives
NCT01140802 ·Status: TERMINATED
-
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT01988961 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
Genetic Studies of Inflammatory Bowel Disease
NCT00340444 ·Status: COMPLETED
-
Search for New Genetic Mutations Major Effect in Crohn's Disease
NCT02851134 ·Status: COMPLETED
-
Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Common Immunodeficiency
NCT05481554 ·Status: UNKNOWN
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Study of an Environmental Risk Factor in Crohn's Disease
NCT04960826 ·Status: RECRUITING
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NCT03809728 ·Status: RECRUITING ·Phase: NA
-
The Microbial Impact on Intestinal Fibrosis and the Associated Immune Microenvironment in Crohn's Disease
NCT06720961 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases
NCT02020382 ·Status: COMPLETED ·Phase: NA
-
Nutrition and Clinical Outcomes in IBD
NCT06550310 ·Status: RECRUITING
-
Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM
NCT01663142 ·Status: COMPLETED